Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrowth improved, but quality of life did not.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

CTP-543 is generally safe for treating alopecia areata.

Careful management of blood thinners is crucial for lupus patients with APS.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.

Stem cell therapy from umbilical cords may help treat atopic dermatitis.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The new gel improves treatment of tough skin infections.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Squaric acid dibutylester effectively treats alopecia areata.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

The new minoxidil and salicylic acid hydrogel improves alopecia treatment.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

Topical sensitizers have mixed success in treating alopecia areata.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.